Avistone Biotechnology Co., Ltd.
Clinical trials sponsored by Avistone Biotechnology Co., Ltd., explained in plain language.
-
New pill takes on stubborn lung cancer in major trial
Disease control ENROLLING_BY_INVITATIONThis phase 3 study tests a new oral drug, PLB1004, against standard chemotherapy for people with advanced non-small-cell lung cancer that has a specific EGFR mutation (exon 20 insertion). About 327 adults with this rare, hard-to-treat cancer will be enrolled. The main goal is to …
Phase: PHASE3 • Sponsor: Avistone Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 12:11 UTC
-
New pill shows promise against tough cancers in early trial
Disease control OngoingThis early-phase study tests a new oral drug, ANS014004, in about 40 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. Participants take the drug daily o…
Phase: PHASE1 • Sponsor: Avistone Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 12:05 UTC